Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers

Annals of Oncology

Volumn 23, Issue 2, 2012, Pages 367-374

  Haan, J C ^a   Buffart, T E ^a   Eijk, P P ^a   van de wiel, M A ^a,b   van wieringen, W N ^a,b   Howdle, P D ^c   Mulder, C J J ^a   van de velde, C J ^d   Quirke, P ^c   Nagtegaal, I D ^e   van grieken, N C T ^a   Grabsch, H ^c   Meijer, G A ^a   Ylstra, B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Array comparative genomic hybridization; Chromosomal copy number aberrations; Formalin fixed paraffin embedded; Hierarchical clustering; Small bowel adenocarcinoma; Treatment

Indexed keywords

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 4P; CHROMOSOME 9P; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE EXPRESSION PROFILING; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MUTATION RATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CARCINOMA; STOMACH CANCER; TREATMENT RESPONSE;

EID: 84856359340     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr122     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E et al.Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Singhal N, Singhal D. Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev 2007; CD005202.
3. Chaiyasate K, Jain AK, Cheung LY et al.Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience. World J Surg Oncol 2008; 6: 12.
4. Zouhairi ME, Venner A, Charabaty A et al.Small bowel adenocarcinoma. Curr Treat Options Oncol 2008; 9: 388-399.
5. Costa JL, Meijer G, Ylstra B et al.Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Semin Radiat Oncol 2008; 18: 98-104.
6. Postma C, Koopman M, Buffart TE et al.DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann Oncol 2009; 20: 1048-1056.
7. Osterberg L, Levan K, Partheen K et al.High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cytogenet Genome Res 2009; 125: 8-18.
8. Climent J, Dimitrow P, Fridlyand J et al.Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Res 2007; 67: 818-826.
9. Jong K, Marchiori E, van der Vaart A et al.Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 2007; 26: 1499-1506.
10. Chin K, DeVries S, Fridlyand J et al.Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006; 10: 529-541.
11. Brosens RP, Haan JC, Carvalho B et al.Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J Pathol 2010 221: 411-424.
12. Carvalho B, Postma C, Mongera S et al.Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009; 58: 79-89.
13. Buffart TE, Carvalho B, Hopmans E et al.Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 2007; 211: 45-51.
14. Diosdado B, Buffart TE, Watkins R et al.High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin Cancer Res 2010; 16: 1391-1401.
15. Bonenkamp JJ, Hermans J, Sasako M et al.Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340: 908-914.
16. Buffart TE, van Grieken NC, Tijssen M et al.High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch 2009; 455: 213-223.
17. Snijders AM, Nowak N, Segraves R et al.Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001 29: 263-264.
18. van den Ijssel P, Tijssen M, Chin SF et al.Human and mouse oligonucleotidebased array CGH. Nucleic Acids Res 2005; 33: e192.
19. Hewish M, Lord CJ, Martin SA et al.Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 2010 7: 197-208.
20. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumours (UICC), 6th edition. New York: Wiley-Liss 2002.
21. van Wieringen WN, van de Wiel MA, Ylstra B. Weighted clustering of called array CGH data. Biostatistics 2008; 9: 484-500.
22. Smeets SJ, Brakenhoff RH, Ylstra B et al.Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis. Cell Oncol 2009; 31: 291-300.
23. van de Wiel MA, van Wieringen WN. CGHregions: dimension reduction for array cgh data with minimal information loss. Cancer Inform 2007; 2: 55-63.
24. van de Wiel MA, Smeets SJ, Brakenhoff RH et al.CGHMultiArray: exact P-values for multi-array comparative genomic hybridization data. Bioinformatics 2005 21: 3193-3194.
25. Smeets SJ, Braakhuis BJ, Abbas S et al.Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006; 25: 2558-2564.
26. Monti S, Tamayo P, Mesirov J et al.Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Machine Learning 2003; 52: 91-118.
27. Kullback S, Leibler RA. On information and sufficiency. Ann Math Statist 1951; 22: 79-86.
28. Hinrichs AS, Karolchik D, Baertsch R et al.The UCSC Genome Browser Database: update 2006. Nucleic Acids Res 2006; 34: D590-D598.
29. Futreal PA, Coin L, Marshall M et al.A census of human cancer genes. Nat Rev Cancer 2004; 4: 177-183.
30. Douglas EJ, Fiegler H, Rowan A et al.Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 2004; 64: 4817-4825.
31. Beroukhim R, Mermel CH, Porter D et al.The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463: 899-905.
32. Blaker H, von Herbay A, Penzel R et al.Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 2002; 21: 158-164.
33. Berkhout M, Nagtegaal ID, Cornelissen SJ et al.Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas. Mod Pathol 2007; 20: 1253-1262.
34. Noguchi T, Wirtz HC, Michaelis S et al.Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001; 115: 828-834.
35. Weiss MM, Kuipers EJ, Postma C et al.Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 2004; 26: 307-317.
36. Myllykangas S, Junnila S, Kokkola A et al.Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer 2008; 123: 817-825.
37. Brucher BL, Geddert H, Langner C et al.Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel. Int J Cancer 2006; 119: 1298-1302.
38. Blaker H, Helmchen B, Bonisch A et al.Mutational activation of the RAS-RAFMAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol 2004; 39: 748-753.
39. Chen ZM, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol 2004; 28: 1352-1359.
40. Overman MJ, Pozadzides J, Kopetz S et al.Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer 2010; 102: 144-150.
41. de Gramont A, Figer A, Seymour M et al.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.
42. Overman MJ, Kopetz S, Wen S et al.Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 2008; 113: 2038-2045.
43. Locher C, Malka D, Boige V et al.Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005; 69: 290-294.
44. Overman MJ, Varadhachary GR, Kopetz S et al.Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol 2009; 27: 2598-2603.
45. Hurwitz H, Fehrenbacher L, Novotny W et al.Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
46. Galsky MD, Zaks T, Hassani H et al.Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics. Invest New Drugs 2010; 28: 194-198.
47. Meza-Junco J, Au HJ, Sawyer MB. Trastuzumab for gastric cancer. Expert Opin Biol Ther 2009; 9: 1543-1551.
48. Overman MJ. Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res 2009; 3: 90-96.